White label ELPA - ClinicalTrials.eu

Study on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations

Not recruiting

2 1 1 1
Investigated drugs:
Effect of BI 1015550 on blood levels of nintedanib and pirfenidone in healthy men

Not recruiting

1 1 1 1
Investigated drugs:
Study on the Effects of Fidrisertib for Treating Fibrodysplasia Ossificans Progressiva in Children and Adults

Not recruiting

2 1
Investigated drugs:
- (R)‑Tetrahydrofuran‑3‑Yl 4‑(6‑(5‑(4‑Ethoxy‑1‑Isopropylpiperidin‑4‑Yl)Pyridin-2-Yl)Pyrrolo[1,2-B]Pyridazin-4-Yl)Piperazine-1-Carboxylate Sesquisuccinate
+2
Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

Not recruiting

3 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
+6
Study on Ticagrelor for Patients with Heart Attack After Coronary Stenting

Not recruiting

2 1 1 1
Investigated drugs:
- Ticagrelor
Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Tirzepatide
Study on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17

Not recruiting

3 1 1 1
Investigated diseases:
- Migraine
Investigated drugs:
- Lasmiditan
+1
Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

Not recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Daxdilimab
- Prednisone
Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Lung adenocarcinoma
Investigated drugs:
Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial

Not recruiting

3 1
Investigated drugs:
- Odevixibat
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies